Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate (Q36930704)
Jump to navigation
Jump to search
scientific article published on 29 November 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate |
scientific article published on 29 November 2007 |
Statements
1 reference
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate (English)
1 reference
M Schiff
1 reference
M Keiserman
1 reference
C Codding
1 reference
S Songcharoen
1 reference
A Berman
1 reference
S Nayiager
1 reference
C Saldate
1 reference
T Li
1 reference
R Aranda
1 reference
J-C Becker
1 reference
C Lin
1 reference
P L N Cornet
1 reference
M Dougados
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference